Beneficial effects of FK506 for experimental temporal lobe epilepsy

Neuroscience Research

Volumn 56, Issue 4, 2006, Pages 386-390

  Nishimura, Tsutomu ^a,b   Imai, Hideki ^c   Minabe, Yoshio ^b   Sawa, Akira ^d   Kato, Nobumasa ^e  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d Program in Cellular and Molecular Medicine   (United States)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Behavioral change; FK506; Kainic acid; Neuronal cell death; Temporal lobe epilepsy; Trimethyltin

Indexed keywords

KAINIC ACID; TRIMETHYLTIN; TSUKUBAENOLIDE;

ABNORMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BRAIN DAMAGE; BRAIN DISEASE; BRAIN ISCHEMIA; CONTROLLED STUDY; IN VITRO STUDY; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; TEMPORAL LOBE EPILEPSY;

AGGRESSION; ANIMALS; ANTICONVULSANTS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY, TEMPORAL LOBE; EXCITATORY AMINO ACID AGONISTS; IMMUNOSUPPRESSIVE AGENTS; IN SITU NICK-END LABELING; KAINIC ACID; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; TACROLIMUS; TRIMETHYLTIN COMPOUNDS;

EID: 33750982433     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.08.006     Document Type: Article

References (24)

1. Babb T.L., and najm I.M. Hippocampal sclerosis. Pathology, electrophysiology, and mechanisms of epileptogenesis. In: Wyllie E. (Ed). The Treatment of Epilepsy Principles and Practice. 3rd ed. (2001), Lippincott Williams and Wilkins, Philadelphia 105-144
2. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14 (1985) 375-403
3. Butcher S.P., Henshall D.C., Teramura Y., Iwasaki K., and Sharkey J. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J. Neurosci. 17 (1997) 6939-6946
4. Dyer R.S., Walsh T.J., Wonderlin W.F., and Bercegeay M. The trimethyltin syndrome in rats. Neurobehav. Toxicol. Teratol. 4 (1982) 127-133
5. Hashimoto K., Watanabe K., Nishimura T., Iyo M., Shirayama Y., and Minabe Y. Behavioral changes and expression of heat shock protein hsp-70 mRNA, brain-derived neurotrophic factor mRNA, and cyclooxygenase-2 mRNA in rat brain following seizures induced by systemic administration of kainic acid. Brain Res. 804 (1998) 212-223
6. Ide T., Morikawa E., and Kirino T. An immunosuppressant, FK506, protects hippocampal neurons from forebrain ischemia in the mongolian gerbil. Neurosci. Lett. 204 (1996) 157-160
7. Imai H., Nishimura T., Sadamatsu M., Liu Y., Kabuto M., and Kato N. Type II glucocorticoid receptors are involved in neuronal death and astrocyte activation induced by trimethyltin in the rat hippocampus. Exp. Neurol. 171 (2001) 22-28
8. Ishida N., Akaike M., Tsutsumi S., Kanai H., Masui A., Sadamatsu M., Kuroda Y., Watanabe Y., McEwen B.S., and Kato N. Trimethyltin syndrome as a hippocampal degeneration model: temporal changes and neurochemical features of seizure susceptibility and learning impairment. Neuroscience 81 (1997) 1183-1191
9. Kirimlioglu H., Kirimlioglu V., Yilmaz S., Coban S., Turkmen E., and Ara C. Liver pathology and cell Proliferation after calcineurin inhibitors and antiproliferative drugs following artial hepatectomy in rats. Transplant. Proc. 38 (2006) 622-626
10. Marmarou C.R., and Povlishock J.T. Administration of the immunophilin ligand FK506 differentially attenuates neurofilament compaction and impaired axonal transport in injured axons following diffuse traumatic brain injury. Exp. Neurol. 197 (2006) 353-362
11. Moriwaki A., Lu Y.F., Hayashi Y., Tomizawa K., Tokuda M., Itano T., Hatase O., and Matsui H. Immunosuppressant FK506 prevents mossy fiber sprouting induced by kindling stimulation. Neurosci. Res. 25 (1996) 191-194
12. Moriwaki A., Lu Y.F., Tomizawa K., and Matsui H. An immunosuppressant, FK506, protects against neuronal dysfunction and death but has no effect on electrographic and behavioral activities induced by systemic kainate. Neuroscience 86 (1998) 855-865
13. Nagatomo I., Hashiguchi W., Tominaga M., Akasaki Y., Uchida M., and Takigawa M. Effects of MK-801, dantrolene, and FK506 on convulsive seizures and brain nitric oxide production in seizure-susceptible EL mice. Brain Res. 888 (2001) 306-310
14. Nishimura T., Schwarzer C., Furtinger S., Imai H., Kato N., and Sperk G. Changes in the GABA-ergic system induced by trimethyltin application in the rat. Brain Res. Mol. Brain Res. 97 (2001) 1-6
15. Pinel J., Treit D., and Rovner L. Temporal lobe aggression in rats. Science 197 (1977) 1088-1089
16. Racine R. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32 (1972) 281-294
17. Schreiber S. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251 (1991) 283-287
18. Sharkey J., and Butcher S.P. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature 371 (1994) 336-339
19. Sloviter R., von Knebel Doeberitz C., Walsh T., and Dempster D. On the role of seizure activity in the hippocampal damage produced by trimethyltin. Brain Res. 367 (1986) 169-182
20. Snyder S., and Sabatini D. Immunophilins and the nervous system. Nature Med. 1 (1995) 32-37
21. Snyder S., Lai M., and Burnett P. Immunophilins in the nervous system. Neuron 21 (1998) 283-294
22. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42 (1994) 1-32
23. Takada K., Usuda H., Oh-Hashi M., Yoshikawa H., Muranishi S., and Tanaka H. Pharmacokinetics of FK-506, a novel immunosuppressant, after intravenous and oral administrations to rats. J. Pharmacol. 14 (1991) 34-42
24. Wallemacq P.E., and Verbeeck R.K. Comparative clinical pharmacokinetics of tacrolims in pediatric and adult patients. Clin. Pharmacokinet. 40 (2001) 283-295